TCG News

Widely considered to be the father of the biotechnology industry, Robert Swanson changed the world when he founded Genentech with Herbert Boyer in 1976. TCG’s new fellowship program pays homage to Robert Swanson’s legacy, empowering the next generation of young visionaries on their quest to better the world through science and medicine. The Column Group […]

TCG’s iPartners represents a new ideation advisory group comprised of leading academic investigators and biotech entrepreneurs. Working closely with TCG’s Swanson Fellows and our core investment team, this group is dedicated to crafting innovative new drug discovery company concepts, drawing on their deep scientific expertise, academic and industry networks, and entrepreneurial intuition. The iPartners consist

The Column Group announced the recruitment of Dr. Eric Olson to the firm’s renowned group of Science Partners. Dr. Olson is the founding Chair of the Department of Molecular Biology at The University of Texas Southwestern Medical Center. He also founded the Center for Regenerative Science and Medicine at UT Southwestern, which is advancing new

The Column Group announces the hiring of Dr. John Josey. Previously, Dr. Josey served as the President, Chief Executive Officer and a member of the Board of Directors of Peloton Therapeutics, from 2013 until its acquisition by Merck in 2019. He joined Peloton in 2011 as the first employee in the role of President and

The Column Group announced the recruitment of Dr. Helen Hobbs to the firm’s renowned group of Science Partners. Dr. Hobbs is Professor of Internal Medicine and Molecular Genetics at the University of Texas Southwestern Medical Center. She is also an investigator at the Howard Hughes Medical Institute.

The Column Group announces the hiring of Dr. Leon Chen. Previously, Dr. Chen was a Venture Partner at Orbimed. Prior to that he was a Partner at Skyline Ventures. Dr. Chen was also a founder of KAI Pharmaceuticals, acquired by Amgen in 2012.

The Column Group announces the promotion of Dr. JJ Kang from Principal to Partner. Dr. Kang has been with TCG since 2015.

The Column Group announced the recruitment of Dr. Vishva Dixit to the firm’s renowned group of Science Partners.  Dr. Dixit is Vice President of Physiological Chemistry at Genentech.  He is a member of the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences and a Foreign Member, European

The Column Group announced the recruitment of Dr. Huda Zoghbi and Dr. Charles Zuker to the firm’s renowned group of Science Partners. Dr. Huda Zoghbi is a professor in the Departments of Pediatrics, Molecular and Human Genetics, Neurology and Neuroscience at Baylor College of Medicine. She is also an investigator at the Howard Hughes Medical